Keyword

AT7519

Description: AT7519 is a small-molecule inhibitor of cyclin-dependent kinases investigated as an anticancer drug in laboratory and clinical research.
Wikidata ID: wiki/Q27074569
OpenAlex ID: keywords/at7519
2021 · Mengna Zhang, Lingxian Zhang, et al. · PubMed · 393
2009 · Matthew S. Squires, Ruth E. Feltell, et al. · Molecular Cancer Therapeutics · 184
2015 · M. Emmy M. Dolman, Evon Poon, et al. · Clinical Cancer Research · 78
2020 · Harri M. Itkonen, Ninu Poulose, et al. · Molecular Cancer Research · 57
2022 · Chao Song, Haitao Li, et al. · Respiratory Research · 51
2018 · Robert A. Hazlitt, Tal Teitz, et al. · Journal of Medicinal Chemistry · 40
2019 · Changlei Xi, Ling Wang, et al. · Biochemical and Biophysical Research Communications · 39
2021 · Aslamuzzaman Kazi, Liwei Chen, et al. · Clinical Cancer Research · 33
2020 · Thomas Robert, Jared L. Johnson, et al. · Frontiers in Chemistry · 31
2020 · Khanh T. Do, Geraldine O’Sullivan Coyne, et al. · Cancer Chemotherapy and Pharmacology · 24
2014 · Solomon O. Odemuyiwa, Ramses Ilarraza, et al. · Immunology · 18
Works count: 119
Citation count: 2,452
Year
Topic
Type